Ryan J. Andreoli
Special Counsel - New York
ryan.andreoli@cwt.com
212 504 6463
Download V-Card
One World Financial Center
New York, NY 10281
Practice areas
Litigation
Corporate & Securities (Lit)
Commercial (Lit)

Schools
New York University School of Law
J.D. 2003

Boston College
B.A., magna cum laude 1999

Articles:
PDF file Class Action Issues in Supreme Court: Assessing the Significance of "Amgen"
New York Law Journal
Jason M. Halper, Ryan J. Andreoli, William J. Foley, Joseph P. Mueller
Apr 03, 2013
More Articles
Clients & Friends Memos:
PDF file  Ninth Circuit’s Harkonen Decision Does Not Undermine Recent Second Circuit Precedent Establishing That Truthful Promotion Of Approved Drugs For Off-Label Use Is Protected By The First Amendment
Mar 22, 2013
More Clients & Friends Memos
Ryan J. Andreoli

Ryan Andreoli's practice is concentrated in the area of complex commercial litigation, with a particular focus on securities and shareholder derivative matters. Ryan represents clients in a variety of state and federal courts, and has played a prominent role in the representation of:

  • The outside directors of Merrill Lynch in shareholder derivative litigation relating to the company's investments in subprime mortgage-related securities.
  • Pfizer Inc. and certain of its directors in federal securities and ERISA class actions and shareholder derivative litigation relating to the marketing and sale of the arthritis drugs Celebrex and Bextra.
  • Deutsche Bank in multiple lawsuits involving numerous financial institutions alleging violations of state securities laws and RICO in connection with certain short selling activities.
  • Walkers Fund Services and two independent directors of the Bear Stearns High Grade Structured Credit Strategies Fund in shareholder derivative litigation arising out of the collapse of two multi-billion dollar hedge funds.
  • A nuclear fuel producer in litigation asserting that it violated RICO by engaging in certain contracting practices.
  • An electronic brokerage firm and its founder in litigation alleging violations of the federal securities laws, breach of contract and common law fraud in connection with the sale of certain subsidiaries to a competitor.
  • A multi-billion dollar hedge fund in an SEC investigation into trading and disclosure practices.
  • Credit Suisse Securities (USA) LLC in litigation involving claims that it breached an oral contact requiring it to convey its interest in a mezzanine loan to the borrower.
  • A real estate investment firm in litigation commenced by a junior loan participant in connection with a contemplated sale of the loan.
  • A military defense contractor in litigation alleging misappropriation of trade secrets and breach of contract by a former employee.
  • Pfizer Inc. in multiple lawsuits arising from its proposed acquisition of Wyeth.

Ryan is actively involved in pro bono work, and received a Pro Bono Publico Award from The Legal Aid Society in 2009 for his work on behalf of Section 8 tenants.

Ryan graduated magna cum laude from Boston College in 1999, and received his J.D. from the New York University School of Law in 2003.

Ryan is admitted to practice in New York, and before the U.S. District Courts for the Southern, Eastern, and Northern Districts of New York.






© 2001-2013 Cadwalader, Wickersham & Taft LLP